EGFR and non-small cell lung cancer: implications for surgical practice

Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Service of Thoracic Surgery, Salamanca University Hospital, Salamanca, Spain Correspondence to: Dr. Gonzalo Varela. Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. Email: gvs@usal.es. Provenance and Peer Review: This article was commissioned by the editorial office, Annals of Translational Medicine. The article did not undergo external peer review. Comment on: Liang W, Cai K, Chen C, et al. Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 Edition). Transl Lung Cancer Res 2019;8:1163-73.